Antimicrobial susceptibilities of Pasteurella strains isolated from humans

International Journal of Antimicrobial Agents

Volumn 27, Issue 4, 2006, Pages 290-293

  Lion, C ^a,b   Conroy, M C ^b   Carpentier, A M ^a   Lozniewski, A ^a,b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Antimicrobial susceptibility; MIC; Pasteurella

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFOTAXIME; CIPROFLOXACIN; CLARITHROMYCIN; LEVOFLOXACIN; MINOCYCLINE; MOXIFLOXACIN; OFLOXACIN; TELITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD SAMPLING; CONTROLLED STUDY; DILUTION; IN VITRO STUDY; METHODOLOGY; NONHUMAN; PASTEURELLA; PRIORITY JOURNAL; PUS; RESPIRATORY TRACT EXAMINATION; SOFT TISSUE;

ANTI-BACTERIAL AGENTS; BLOOD; HUMANS; INSECT BITES AND STINGS; MICROBIAL SENSITIVITY TESTS; PASTEURELLA; PASTEURELLA INFECTIONS; RESPIRATORY TRACT DISEASES; SUPPURATION;

EID: 33645957378     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.02.004     Document Type: Article

References (22)

1. Escande F., and Lion C. Epidemiology of human infections by Pasteurella and related groups in France. Zentralbl Bakteriol 279 (1993) 131-139
2. Klein N., and Cunha B.A. Pasteurella multocida pneumonia. Semin Respir Infect 12 (1997) 54-56
3. Breen D., Schonell M., Au T., and Reiss-Levy E. Pasteurella multocida: a case report of bacteremic pneumonia and 10-year laboratory review. Pathology 32 (2000) 152-153
4. Byrd Jr. R.P., and Roy T.M. Pasteurella multocida respiratory infection: an important cat-associated zoonosis. Arch Intern Med 163 (2003) 1239
5. Draenert R., Kunzelmann M., Roggenkamp A., Hellers J., and Bogner J.R. Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin. Eur J Clin Microbiol Infect Dis 24 (2005) 288-290
6. Stefanopoulos P.K., and Tarantzopoulou A.D. Facial bite wounds: management update. Int J Oral Maxillofac Surg 34 (2005) 464-472
7. Heurtin C., Desbordes L., Travert M.F., Donnio P.Y., and Avril J.L. Comparative study of the bacteriostatic and bactericidal activity of levofloxacin against Pasteurella strains isolated from man. Pathol Biol 49 (2001) 606-611
8. Goldstein E.J.C., Citron D.M., Gerardo S.H., Hudspeth M., and Merriam C.V. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. Antimicrob Agents Chemother 42 (1998) 1127-1132
9. Goldstein E.J.C., Citron D.M., Merriam C.V., Warren Y., and Tyrrell K. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections. Antimicrob Agents Chemother 44 (2000) 2525-2529
10. Mutters R., Ihm P., Pohl S., Frederiksen W., and Mannheim W. Reclassification of the genus Pasteurella Trevisan 1887 on the basis of deoxyribonucleic acid homology, with proposals for the new species Pasteurella dagmatis, Pasteurella canis, Pasteurella stomatis, Pasteurella anatis, and Pasteurella langaa. Int J Syst Bacteriol 35 (1985) 309-322
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards M7-A6. Wayne, PA: NCCLS; 2003.
12. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Proposed guideline M45-P. Wayne, PA: CLSI; 2005.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 14th Informational Supplement M100-S14. Wayne, PA: NCCLS; 2004.
14. Kehrenberg C., Schulze-Tanzil G., Martel J.L., Chaslus-Dancla E., and Schwartz S. Antimicrobial resistance in Pasteurella and Mannheimia: epidemiology and genetic basis. Vet Res 32 (2001) 323-339
15. Mesnard R., Donnio P.Y., Denis F., Phillipon A., and Avril J.L. Une deuxième souche de Pasteurella multocida d'origine humaine productrice d'une β-lactamase. Med Mal Infect 19 (1989) 422-423
16. Nguyen Phuong T., Rosenau A., Philippon A., Moyen E.N., Fauchère J.L., and Patri B. Human pulmonary infection by a strain of Pasteurella multocida producing β-lactamase. Presse Med 18 (1989) 1886 [in French]
17. Gaillot O., Guilbert L., Maruejouls C., Escande F., and Simonet M. In-vitro susceptibility to thirteen antibiotics of Pasteurella spp. and related bacteria isolated from humans. J Antimicrob Chemother 36 (1995) 878-880
18. Naas T., Benaoudia F., Lebrun L., and Nordmann P. Molecular identification of TEM-1 beta-lactamase in a Pasteurella multocida of human origin. Eur J Clin Microbiol Infect Dis 20 (2001) 210-213
19. Rosenau A., Labigne A., Escande F., Courcoux P., and Philippon A. Plasmid-mediated ROB-1 β-lactamase in Pasteurella multocida from a human specimen. Antimicrob Agents Chemother 35 (1991) 2419-2422
20. Mortensen J.E., Giger O., and Rodgers G.L. In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida. Diagn Microbiol Infect Dis 30 (1998) 99-102
21. Citron D.M., Warren Y.A., Fernandez H.T., Goldstein M.A., Tyrrell K.L., and Goldstein E.J.C. Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens. J Clin Microbiol 43 (2005) 2485-2488
22. Jorgensen J.H. Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria. J Clin Microbiol 42 (2004) 493-496